Dermatophagoides farinae-specific immunotherapy in atopic dogs with hypersensitivity to multiple allergens: A randomised, double blind, placebo-controlled study

T. Willemse, M. Bardagi, D. N. Carlotti, L. Ferrer, A. Fondati, J. Fontaine, M. Leistra, C. Noli, L. Ordeix, F. Scarampella, S. Schleifer, J. Sinke, P. Roosje

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)

Abstract

A randomised, placebo-controlled, double blind study was conducted on 25 dogs that had atopic dermatitis, together with skin test reactivity and elevated serum IgE to Dermatophagoides farinae (Df) and at least one additional allergen. Dogs were treated with either a Df-restricted immunotherapy solution (n = 14) or a placebo (n = 11) and evaluated 6 weeks and 3, 5, 7 and 9 months after the initiation of treatment using a clinical scoring system (SASSAD) and pruritus analogue scale scores. The Df-restricted solution and the placebo had an equal effect on both pruritus and the skin manifestations (P > 0.05). The results of this study indicate that in dogs with atopic dermatitis based on hypersensitivity to environmental allergens in addition to D. farinae, Df-restricted immunotherapy is insufficient to control the disease. Consequently, a solution for allergen-specific immunotherapy should remain customised. © 2008 Elsevier Ltd. All rights reserved.
Original languageEnglish
Pages (from-to)337-342
JournalVeterinary Journal
Volume180
Issue number3
DOIs
Publication statusPublished - 1 Jun 2009

Keywords

  • Allergen-specific immunotherapy
  • Atopic dermatitis
  • Canine
  • Dermatophagoides farinae

Fingerprint Dive into the research topics of 'Dermatophagoides farinae-specific immunotherapy in atopic dogs with hypersensitivity to multiple allergens: A randomised, double blind, placebo-controlled study'. Together they form a unique fingerprint.

Cite this